Table of Contents EMEA (Europe, Middle East and Africa) RNA-based Biopharmaceuticals Market Report 2018 1 RNA-based Biopharmaceuticals Overview 1.1 Product Overview and Scope of RNA-based Biopharmaceuticals 1.2 Classification of RNA-based Biopharmaceuticals 1.2.1 EMEA RNA-based Biopharmaceuticals Market Size (Sales) Comparison by Type (2013-2025) 1.2.2 EMEA RNA-based Biopharmaceuticals Market Size (Sales) Market Share by Type (Product Category) in 2017 1.2.3 Therapeutics 1.2.4 Vaccines 1.3 EMEA RNA-based Biopharmaceuticals Market by Application/End Users 1.3.1 EMEA RNA-based Biopharmaceuticals Sales (Volume) and Market Share Comparison by Application (2013-2025) 1.3.2 Cancer 1.3.3 Diabetes 1.3.4 Tuberculosis 1.3.5 Cardiovascular Diseases 1.3.6 Others 1.4 EMEA RNA-based Biopharmaceuticals Market by Region 1.4.1 EMEA RNA-based Biopharmaceuticals Market Size (Value) Comparison by Region (2013-2025) 1.4.2 Europe Status and Prospect (2013-2025) 1.4.3 Middle East Status and Prospect (2013-2025) 1.4.4 Africa Status and Prospect (2013-2025) 1.5 EMEA Market Size (Value and Volume) of RNA-based Biopharmaceuticals (2013-2025) 1.5.1 EMEA RNA-based Biopharmaceuticals Sales and Growth Rate (2013-2025) 1.5.2 EMEA RNA-based Biopharmaceuticals Revenue and Growth Rate (2013-2025) 2 EMEA RNA-based Biopharmaceuticals Competition by Manufacturers/Players/Suppliers, Region, Type and Application 2.1 EMEA RNA-based Biopharmaceuticals Market Competition by Players/Manufacturers 2.1.1 EMEA RNA-based Biopharmaceuticals Sales Volume and Market Share of Major Players (2013-2018) 2.1.2 EMEA RNA-based Biopharmaceuticals Revenue and Share by Players (2013-2018) 2.1.3 EMEA RNA-based Biopharmaceuticals Sale Price by Players (2013-2018) 2.2 EMEA RNA-based Biopharmaceuticals (Volume and Value) by Type/Product Category 2.2.1 EMEA RNA-based Biopharmaceuticals Sales and Market Share by Type (2013-2018) 2.2.2 EMEA RNA-based Biopharmaceuticals Revenue and Market Share by Type (2013-2018) 2.2.3 EMEA RNA-based Biopharmaceuticals Sale Price by Type (2013-2018) 2.3 EMEA RNA-based Biopharmaceuticals (Volume) by Application 2.4 EMEA RNA-based Biopharmaceuticals (Volume and Value) by Region 2.4.1 EMEA RNA-based Biopharmaceuticals Sales and Market Share by Region (2013-2018) 2.4.2 EMEA RNA-based Biopharmaceuticals Revenue and Market Share by Region (2013-2018) 2.4.3 EMEA RNA-based Biopharmaceuticals Sales Price by Region (2013-2018) 3 Europe RNA-based Biopharmaceuticals (Volume, Value and Sales Price), by Players, Countries, Type and Application 3.1 Europe RNA-based Biopharmaceuticals Sales and Value (2013-2018) 3.1.1 Europe RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2013-2018) 3.1.2 Europe RNA-based Biopharmaceuticals Reven

List of Tables and Figures Figure Product Picture of RNA-based Biopharmaceuticals Figure EMEA RNA-based Biopharmaceuticals Sales Volume (K Units) by Type (2013-2025) Figure EMEA RNA-based Biopharmaceuticals Sales Volume Market Share by Type (Product Category) in 2017 Figure Therapeutics Product Picture Figure Vaccines Product Picture Figure EMEA RNA-based Biopharmaceuticals Sales Volume (K Units) by Application (2013-2025) Figure EMEA Sales Market Share of RNA-based Biopharmaceuticals by Application in 2017 Figure Cancer Examples Table Key Downstream Customer in Cancer Figure Diabetes Examples Table Key Downstream Customer in Diabetes Figure Tuberculosis Examples Table Key Downstream Customer in Tuberculosis Figure Cardiovascular Diseases Examples Table Key Downstream Customer in Cardiovascular Diseases Figure Others Examples Table Key Downstream Customer in Others Figure EMEA RNA-based Biopharmaceuticals Market Size (Million USD) by Region (2013-2025) Figure Europe RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025) Figure Europe RNA-based Biopharmaceuticals Revenue (Million USD) Status and Forecast by Countries Figure Middle East RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025) Figure Middle East RNA-based Biopharmaceuticals Revenue (Million USD) Status and Forecast by Countries Figure Africa RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025) Figure Africa RNA-based Biopharmaceuticals Revenue (Million USD) Status and Forecast by Countries Figure EMEA RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2013-2025) Figure EMEA RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025) Figure EMEA RNA-based Biopharmaceuticals Market Major Players Product Sales Volume (K Units) (2013-2018) Table EMEA RNA-based Biopharmaceuticals Sales Volume (K Units) of Major Players (2013-2018) Table EMEA RNA-based Biopharmaceuticals Sales Share by Players (2013-2018) Figure 2017 RNA-based Biopharmaceuticals Sales Share by Players Figure 2017 RNA-based Biopharmaceuticals Sales Share by Players Figure EMEA RNA-based Biopharmaceuticals Market Major Players Product Revenue (Million USD) (2013-2018) Table EMEA RNA-based Biopharmaceuticals Revenue (Million USD) by Players (2013-2018) Table EMEA RNA-based Biopharmaceuticals Revenue Share by Players (2013-2018) Table 2017 EMEA RNA-based Biopharmaceuticals Revenue Share by Players Table 2017 EMEA RNA-based Biopharmaceuticals Revenue Share by Players Table EMEA RNA-based Biopharmaceuticals Sale Price (USD/Unit) by Players (2013-2018) Table EMEA RNA-based Biopharmaceuticals Sales (K Units) and Market Share by Type (2013-2018) Table EMEA RNA-based Biopharmaceuticals Sales Share by Type (2013-2018) Figure Sales Market Share of RNA-based Biopharmaceuticals by